Q1 2006 PDL BioPharma Earnings Conference Call - Research and Markets offers a brief of 'PDL BioPharma' Conference Call.DUBLIN, Ireland -- The PDL See page description language. 1. PDL - Page Description Language. 2. PDL - Program Design Language. 3. PDL - Push Down List. 4. PDL - Dave Lebling, one of the co-authors of Zork. BioPharma (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :PDLI) Corporate Conference Call took place on 2-May-06 4:30pm ET. Co. reported 1Q06 total revenues of $90.5m. 1Q06 non-GAAP net income was $2.5m. 1Q06 non-GAAP EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. was $0.02 per basic and diluted share. 1Q06 GAAP GAAP See: Generally Accepted Accounting Principles GAAP See generally accepted accounting principles (GAAP). net loss was $26.2m. 1Q06 GAAP loss per share was $0.23. For full-year 2006, PDLI expects total revenues of $400-430m. Full-year 2006 non-GAAP net income is expected to be between $8-23m. Full-year 2006 non-GAAP EPS is expected to be between $0.07-0.19. More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/87007 This document provides a non-biased summary of the conference call detailing the key points and the full Q&A session. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion